We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Conagra (CAG) Q1 Earnings & Sales Lag Estimates, Stock Down
Read MoreHide Full Article
Conagra Brands, Inc. (CAG - Free Report) posted first-quarter fiscal 2019 results, wherein both earnings and sales improved year over year but came below the Zacks Consensus Estimate. Conagra’s shares tumbled 5.4% during the pre-market trading session. Further, this Zacks Rank #4 (Sell) stock has declined 2.7% year to date compared with the industry’s decline of 6.8%.
During the first quarter, the company concluded the sale of its Canadian Del Monte processed fruit and vegetable business to Bonduelle Group. Further, Conagra remains on track to acquire Pinnacle Foods , which is expected to close by the end of October 2018, subject to certain approvals.
Earnings & Sales
Conagra’s quarterly adjusted earnings from continuing operations rose 2.2% to 47 cents, though it fell short of the Zacks Consensus Estimate of 49 cents. Notably, this marked the company’s first earnings miss after four consecutive beats. The year-over-year upside was backed by reduced effective tax rate and lower share count, which compensated for escalated SG&A expenses, reduced equity method investment earnings, and a decline in pension and post-retirement non-service income.
Conagra Brands Inc. Price, Consensus and EPS Surprise
Conagra generated net sales of $1,834.4 million, which climbed 1.7% year over year but came below the Zacks Consensus Estimate of $1,847 million. Sales growth was driven by contributions from Angie's BOOMCHICKAPOP and Sandwich Bros. buyouts to the tune of about 200 (basis points) bps.
On the contrary, divestitures of Trenton production facility and the Canadian Del Monte business weighed on sales growth to the tune of 120 bps. Continued strength in Refrigerated & Frozen and Grocery & Snacks segments, in particular, also drove sales.
Further, organic sales (excluding Trenton) inched up 1.2%, courtesy of strength in all four segments. During the quarter, volumes remained flat, whereas price/mix improved. Higher volumes at Refrigerated & Frozen, Grocery & Snacks, and International segments were negated by the effects of value-over-volume strategy in the company’s Foodservice segment. As for price/mix, the same was backed by better pricing and mix, which more than offset higher retailer investments to aid brand saliency, customer trial and improved distribution.
Gross Margin
Adjusted gross profit fell 0.6% to $524.2 million, with adjusted gross margin contracting 60 bps to 28.6%. The downside stemmed from elevated transportation and input costs, and greater retailer investments. This was somewhat cushioned by supply-chain productivity, improved price/mix and gains from recent buyouts.
Segmental Details
Grocery & Snacks: The segment’s quarterly sales came in at $771 million, up 3.4% year over year. Notably, Angie's BOOMCHICKAPOP acquisition contributed nearly 330 bps to net sales growth. Organic sales grew just 0.1% as volumes rose 0.1% but price/mix remained flat.
Volume growth was fueled by strength in snacks items like Slim Jim, Duke's, Act II and Orville Redenbacher's along with solid Chef Boyardee strong performance. These factors negated softness in various non-key grocery brands.
Refrigerated & Frozen: Net sales jumped 3.2% to $635 million, as Sandwich Bros.’ buyout contributed about 180 bps to net sales growth. Organic sales increased 1.4%. Markedly, volumes and price/mix increased 0.5% and 0.9%, respectively. Volumes were backed by focus on innovation in certain categories.
International: Net sales climbed 1.5% to $194 million, which was hurt by adverse currency movements to the tune of about 320 bps. Further, Angie's BOOMCHICKAPOP buyout boosted net sales growth by nearly 90 bps, whereas the divestiture of the Canadian Del Monte business lowered net sales growth by roughly 250 bps.
On an organic basis, net sales jumped 6.8%, courtesy of 4.4% volume growth, which was backed by improved snacks businesses in Mexico and Canada. Also, price/mix grew 1.9%, owing to better pricing.
Foodservice: The segment’s quarterly sales declined 6.9% year over year to $234 million, owing to Trenton sale that accounted for about 700 bps of the decline. Organic sales climbed 0.1%, owing to soft volumes, which fell 5% due to the company’s focus on its value-over-volume strategy.
This strategy caused the company to exit certain under-performing businesses, which weighed on volumes. Price/mix rose 5.1% on the back of favorable product mix and better pricing, countering inflation.
Other Financial Fundamentals
Advertising and promotion (A&P) costs were 22.1% lower at $43 million, as management continues to shift investments from A&P marketing to the aforementioned retailer investments. Further, equity method investment earnings slumped nearly 46% to $16 million.
Conagra exited the quarter with cash and cash equivalents of $74.8 million, senior long-term debt (excluding current portion) of $3,037.8 million and total stockholders’ equity of $3,815.0 million. In the first quarter, the company generated net cash of $94.7 million from operating activities (continued operations).
During the quarter, Conagra paid quarterly dividend per share of 21.25 cents. Further, management intends to retain its existing annual dividend per share rate during fiscal 2019, owing to Pinnacle Foods’ buyout.
Fiscal 2019 & Q2 Outlook
Conagra reiterated its outlook for fiscal 2019. Net sales are anticipated to increase 0.5-1.5%. Organic sales are expected to increase 1-2%, excluding the impacts from the sale of the Trenton facility.
Adjusted gross margin is expected to be 29.7-30.0%, while input cost inflation is guided between 3.0% and 3.2%. Management projects adjusted operating margin to be 15.0-15.3%. Effective tax rate is likely to be 23-24%.
Q2 View
Organic net sales growth (excluding Trenton) is expected between flat and slightly down. Net sales growth is anticipated to be nearly 40 bps lower than organic net sales growth. Adjusted operating margin is expected to be 14.4-14.7%.
Finally, Conagra envisions adjusted earnings to be 57-60 cents per share for the second quarter. The Zacks Consensus Estimate is currently pegged at 64 cents.
Chefs’ Warehouse (CHEF - Free Report) , with long-term earnings per share growth rate of 22%, carries a Zacks Rank #2 (Buy).
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Conagra (CAG) Q1 Earnings & Sales Lag Estimates, Stock Down
Conagra Brands, Inc. (CAG - Free Report) posted first-quarter fiscal 2019 results, wherein both earnings and sales improved year over year but came below the Zacks Consensus Estimate. Conagra’s shares tumbled 5.4% during the pre-market trading session. Further, this Zacks Rank #4 (Sell) stock has declined 2.7% year to date compared with the industry’s decline of 6.8%.
During the first quarter, the company concluded the sale of its Canadian Del Monte processed fruit and vegetable business to Bonduelle Group. Further, Conagra remains on track to acquire Pinnacle Foods , which is expected to close by the end of October 2018, subject to certain approvals.
Earnings & Sales
Conagra’s quarterly adjusted earnings from continuing operations rose 2.2% to 47 cents, though it fell short of the Zacks Consensus Estimate of 49 cents. Notably, this marked the company’s first earnings miss after four consecutive beats. The year-over-year upside was backed by reduced effective tax rate and lower share count, which compensated for escalated SG&A expenses, reduced equity method investment earnings, and a decline in pension and post-retirement non-service income.
Conagra Brands Inc. Price, Consensus and EPS Surprise
Conagra Brands Inc. Price, Consensus and EPS Surprise | Conagra Brands Inc. Quote
Conagra generated net sales of $1,834.4 million, which climbed 1.7% year over year but came below the Zacks Consensus Estimate of $1,847 million. Sales growth was driven by contributions from Angie's BOOMCHICKAPOP and Sandwich Bros. buyouts to the tune of about 200 (basis points) bps.
On the contrary, divestitures of Trenton production facility and the Canadian Del Monte business weighed on sales growth to the tune of 120 bps. Continued strength in Refrigerated & Frozen and Grocery & Snacks segments, in particular, also drove sales.
Further, organic sales (excluding Trenton) inched up 1.2%, courtesy of strength in all four segments. During the quarter, volumes remained flat, whereas price/mix improved. Higher volumes at Refrigerated & Frozen, Grocery & Snacks, and International segments were negated by the effects of value-over-volume strategy in the company’s Foodservice segment. As for price/mix, the same was backed by better pricing and mix, which more than offset higher retailer investments to aid brand saliency, customer trial and improved distribution.
Gross Margin
Adjusted gross profit fell 0.6% to $524.2 million, with adjusted gross margin contracting 60 bps to 28.6%. The downside stemmed from elevated transportation and input costs, and greater retailer investments. This was somewhat cushioned by supply-chain productivity, improved price/mix and gains from recent buyouts.
Segmental Details
Grocery & Snacks: The segment’s quarterly sales came in at $771 million, up 3.4% year over year. Notably, Angie's BOOMCHICKAPOP acquisition contributed nearly 330 bps to net sales growth. Organic sales grew just 0.1% as volumes rose 0.1% but price/mix remained flat.
Volume growth was fueled by strength in snacks items like Slim Jim, Duke's, Act II and Orville Redenbacher's along with solid Chef Boyardee strong performance. These factors negated softness in various non-key grocery brands.
Refrigerated & Frozen: Net sales jumped 3.2% to $635 million, as Sandwich Bros.’ buyout contributed about 180 bps to net sales growth. Organic sales increased 1.4%. Markedly, volumes and price/mix increased 0.5% and 0.9%, respectively. Volumes were backed by focus on innovation in certain categories.
International: Net sales climbed 1.5% to $194 million, which was hurt by adverse currency movements to the tune of about 320 bps. Further, Angie's BOOMCHICKAPOP buyout boosted net sales growth by nearly 90 bps, whereas the divestiture of the Canadian Del Monte business lowered net sales growth by roughly 250 bps.
On an organic basis, net sales jumped 6.8%, courtesy of 4.4% volume growth, which was backed by improved snacks businesses in Mexico and Canada. Also, price/mix grew 1.9%, owing to better pricing.
Foodservice: The segment’s quarterly sales declined 6.9% year over year to $234 million, owing to Trenton sale that accounted for about 700 bps of the decline. Organic sales climbed 0.1%, owing to soft volumes, which fell 5% due to the company’s focus on its value-over-volume strategy.
This strategy caused the company to exit certain under-performing businesses, which weighed on volumes. Price/mix rose 5.1% on the back of favorable product mix and better pricing, countering inflation.
Other Financial Fundamentals
Advertising and promotion (A&P) costs were 22.1% lower at $43 million, as management continues to shift investments from A&P marketing to the aforementioned retailer investments. Further, equity method investment earnings slumped nearly 46% to $16 million.
Conagra exited the quarter with cash and cash equivalents of $74.8 million, senior long-term debt (excluding current portion) of $3,037.8 million and total stockholders’ equity of $3,815.0 million. In the first quarter, the company generated net cash of $94.7 million from operating activities (continued operations).
During the quarter, Conagra paid quarterly dividend per share of 21.25 cents. Further, management intends to retain its existing annual dividend per share rate during fiscal 2019, owing to Pinnacle Foods’ buyout.
Fiscal 2019 & Q2 Outlook
Conagra reiterated its outlook for fiscal 2019. Net sales are anticipated to increase 0.5-1.5%. Organic sales are expected to increase 1-2%, excluding the impacts from the sale of the Trenton facility.
Adjusted gross margin is expected to be 29.7-30.0%, while input cost inflation is guided between 3.0% and 3.2%. Management projects adjusted operating margin to be 15.0-15.3%. Effective tax rate is likely to be 23-24%.
Q2 View
Organic net sales growth (excluding Trenton) is expected between flat and slightly down. Net sales growth is anticipated to be nearly 40 bps lower than organic net sales growth. Adjusted operating margin is expected to be 14.4-14.7%.
Finally, Conagra envisions adjusted earnings to be 57-60 cents per share for the second quarter. The Zacks Consensus Estimate is currently pegged at 64 cents.
Check Out These Solid Food Stocks
Medifast (MED - Free Report) , with a Zacks Rank #1 (Strong Buy), delivered positive earnings surprise in the last four quarters. You can see the complete list of today’s Zacks #1 Rank stocks here.
Chefs’ Warehouse (CHEF - Free Report) , with long-term earnings per share growth rate of 22%, carries a Zacks Rank #2 (Buy).
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>